We are delighted to welcome you to the Summer 2019 edition of the European Journal of Arrhythmia & Electrophysiology. This is an especially important edition for us, as it is our first as the official journal of the Arrhythmia Alliance. This exciting new partnership, which sees us collaborate with Arrhythmia Alliance, AF Association and STARS, is detailed in this edition’s foreword, along with an expert interview with Trudie Lobban MBE and Professor John Camm who are two key driving forces behind the Arrhythmia Alliance.
We hope you enjoy this edition, including topical editorials, reviews and case reports. We welcome colleagues in the field to submit their work to our winter edition – visit our submission page for more details.
Foreword – European Journal of Arrhythmia & Electrophysiology. 2019;5(1):9
This edition of European Journal of Arrhythmia & Electrophysiology opens with some exciting news! We are delighted to announce the new partnership between touchCARDIO and the Arrhythmia Alliance, and we look forward to supporting ongoing work in arrhythmia awareness and education – for example at the recent World Heart Rhythm Week (3–9 June). The European […]
Arrhythmia Alliance and the Partnership with touchCARDIO
Cardiac arrhythmias are an increasingly common challenge in global healthcare. Atrial fibrillation is the most common arrhythmia and, over the past 30 years, it has been associated with increasing healthcare burden and patient mortality, in line with rising incidence and prevalence.1 Atrial fibrillation represents a growing global epidemic with prevalence expected to double by 2030.2 […]
Electrocardiograms Associated with Sudden Cardiac Death
Sudden cardiac death arises from the unexpected stopping of the heart and is associated with up to a half of cardiovascular deaths. We discuss with Professor Martin Borggrefe how to identify patient populations at risk of sudden cardiac death (SCD) and how we can use diagnostic tools in at-risk patients. Effective detection, diagnosis, intervention […]
The CABANA Debate – Once a Treatment Becomes Popular, it is Hard to Interpret the Results in Medicine
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in clinical practice, and catheter ablation of AF is currently one of the most commonly performed electrophysiology procedures. Growing experience with ablation techniques, and better AF suppression compared with antiarrhythmic medication, has paved the way for its extended use and indication. The CABANA (Catheter Ablation […]
Updates on Direct Oral Anticoagulants in the Management of Atrial Fibrillation
Anticoagulants play a significant role in stroke prevention caused by atrial fibrillation (AF), which is the most common cardiac arrhythmia. It is estimated that more than five million people in the US and more than eight million people in Europe have AF.1 For many years, vitamin K antagonists, such as warfarin, were the only oral […]
Atrial Fibrillation Ablation – Benefits Beyond Symptom Reduction with a Focus on Patients with Heart Failure with Reduced Ejection Fraction
Catheter ablation for atrial fibrillation (AF) is now a widely established treatment to prevent AF recurrence. Catheter ablation usually involves the isolation of the pulmonary veins, which is an adequate strategy in the majority of cases with paroxysmal AF. Persistent AF, however, often requires additional substrate modification.1–3 Several strategies of substrate modification are under evaluation. […]
Current Endocardial Approaches for Left Atrial Appendage Closure
Atrial fibrillation (AF) is the most commonly encountered sustained arrhythmia and its prevalence and incidence are on the rise as the aging of the population increases.1 AF has been described as an emerging epidemic of cardiovascular disease, with significant effects on estimated disability and mortality, and is rapidly turning into a major public health concern. […]
Novel Oral Anticoagulants – Do Real-world Data Support our Expectations?
Atrial fibrillation (AF) is one of the most common cardiac diseases in elderly patients and is associated with increased morbidity and mortality. It is of great importance to treat patients with AF with oral anticoagulants (OACs) to prevent ischaemic strokes, which represents the most relevant complication of AF. For many decades, vitamin K antagonists (VKAs) […]
Normalised Heart Rate Variability After Sacubitril/Valsartan
We report the case of a 44-year-old woman with a history of chronic heart failure with reduced ejection fraction (HFrEF) due to ischemic cardiomyopathy (New York Heart Association [NYHA] class II). In 2010, she had a myocardial infarction with thrombotic occlusion of the left anterior descending coronary artery, alleged in the context of an essential thrombocythaemia. […]